AB
Insider buying
AH Bio Fund IV, L.P. bought $19.8M of BRVE stock
AH Bio Fund IV, L.P., 10% owner of Braveheart Bio, Inc. (BRVE), bought 1,100,000 shares of BRVE stock worth $19.8M, per an SEC Form 4 filed Aug 11, 2026.
It was an open-market purchase.
The trade happened on Aug 7, 2026, 4 days before it was made public.
BRVE has moved -28.5% since the trade date, from $30.00 to $21.44 (Oct 23, 2026 close).
- Traded
- Aug 7, 2026
- Disclosed
- Aug 11, 2026
- Filing delay
- 4 days
- Price since
- -28.5%
- Role
- 10% owner
- Source
- SEC Form 4
More BRVE insider and Congress trades
- BuyBRVE · Erez Chimovits$34.9MAug 11, 2026
- BuyBRVE · Orbimed Advisors LLC$34.9MAug 11, 2026
- BuyBRVE · Forbion Growth Opportunities Fund III Cooperatief U.A.$64.8MAug 7, 2026
- BuyBRVE · Travis Murdoch$1.5MAug 7, 2026
- BuyBRVE · David Charles Lubner$1000KAug 7, 2026
- BuyBRVE · James Paul Rickey$500KAug 7, 2026
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.